Acino International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile.
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Acino International AG (Acino), formerly Acino Holding AG, manufactures and commercializes generic and prescription pharmaceuticals in novel drug delivery forms. It focuses in the therapeutic areas of oncology, cardiology and metabolism, central nervous system, gastroenterology, infectiology, pain and rheumatology, respiratory, urology and womens health, among others. It also offers business-to-business services such as product development, registration and contract manufacturing. The companys drug delivery technologies focus on modified release oral forms and oral dispersible forms. Acino has manufacturing facilities in Estonia, Switzerland and Ukraine. The company markets its products in the Middle East, Latin America, Africa and Asia. Acino is headquartered in Zurich, Switzerland.
Acino International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Acino International AG (Acino), formerly Acino Holding AG, manufactures and commercializes generic and prescription pharmaceuticals in novel drug delivery forms. It focuses in the therapeutic areas of oncology, cardiology and metabolism, central nervous system, gastroenterology, infectiology, pain and rheumatology, respiratory, urology and womens health, among others. It also offers business-to-business services such as product development, registration and contract manufacturing. The companys drug delivery technologies focus on modified release oral forms and oral dispersible forms. Acino has manufacturing facilities in Estonia, Switzerland and Ukraine. The company markets its products in the Middle East, Latin America, Africa and Asia. Acino is headquartered in Zurich, Switzerland.
Acino International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
2
List of Tables 4
List of Figures 5
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Acino International AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Acino International AG, Medical Devices Deals, 2011 to YTD 2017 10
Acino International AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Acino International AG, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Norgine Divests its MENA Operations and Product Rights to Acino 13
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 14
Acino Pharma Completes Acquisition Of Asia, Latin America, Middle East And Africa Businesses From Mepha For US$123 Million 14
Private Equity 16
Avista Capital And Nordic Capital To Acquire Acino For US$439.93 Million 16
Partnerships 17
Litha Pharma Partners with Gland Pharma 17
Litha Pharma Partners with NTC 18
Litha Healthcare Enters Into Co-Development Agreement With Micro Labs 18
Litha Pharma Partners with Natco Pharma 19
Berlin Pharma Enters Into Co-Marketing Agreement With Acino Pharma 20
Licensing Agreements 21
Acino Pharma Extends its Licensing Agreement with AFT Pharma 21
Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 22
Acino Holding Enters Into Licensing Agreement With Sawai Pharma 23
Acino Holding Enters Into Licensing Agreement With Novartis For Rivastigmine 23
Asset Transactions 24
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 24
Life Sciences Management Group Acquires Iclaprim Business from Acino Pharma 25
Acquisition 26
Acino Pharma Acquires Litha Healthcare from Endo International 26
Acino Pharma Acquires Pharma Start 27
Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For US$60.7 Million 27
Litha Healthcare Acquires OTC Pharma South Africa 29
Litha Healthcare Acquires Goldex Healthcare For US$4 Million 29
Acino International AG - Key Competitors 31
Key Employees 32
Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 35
Corporate Communications 35
Apr 19, 2016: Appointment of Kalle Kand as CEO Acino Group 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List Of Tables
Acino International AG, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Acino International AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Acino International AG, Deals By Therapy Area, 2011 to YTD 2017 9
Acino International AG, Medical Devices Deals, 2011 to YTD 2017 10
Acino International AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Norgine Divests its MENA Operations and Product Rights to Acino 13
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 14
Acino Pharma Completes Acquisition Of Asia, Latin America, Middle East And Africa Businesses From Mepha For US$123 Million 14
Avista Capital And Nordic Capital To Acquire Acino For US$439.93 Million 16
Litha Pharma Partners with Gland Pharma 17
Litha Pharma Partners with NTC 18
Litha Healthcare Enters Into Co-Development Agreement With Micro Labs 18
Litha Pharma Partners with Natco Pharma 19
Berlin Pharma Enters Into Co-Marketing Agreement With Acino Pharma 20
Acino Pharma Extends its Licensing Agreement with AFT Pharma 21
Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 22
Acino Holding Enters Into Licensing Agreement With Sawai Pharma 23
Acino Holding Enters Into Licensing Agreement With Novartis For Rivastigmine 23
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 24
Life Sciences Management Group Acquires Iclaprim Business from Acino Pharma 25
Acino Pharma Acquires Litha Healthcare from Endo International 26
Acino Pharma Acquires Pharma Start 27
Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For US$60.7 Million 27
Litha Healthcare Acquires OTC Pharma South Africa 29
Litha Healthcare Acquires Goldex Healthcare For US$4 Million 29
Acino International AG, Key Competitors 31
Acino International AG, Key Employees 32
Acino International AG, Other Locations 33
Acino International AG, Subsidiaries 33
List Of Figures
Acino International AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Acino International AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Acino International AG, Medical Devices Deals, 2011 to YTD 2017 10
RELATED REPORTS
Acino International AG - Strategic SWOT Analysis Review
Acino International AG - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information
View ReportBenteler International AG - Strategy, SWOT and Corporate Finance Report
Benteler International AG - Strategy, SWOT and Corporate Finance ReportBenteler International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report
View ReportSpecialized Warehousing And Storage Global Market Report 2021: COVID 19 Impact and Recovery to 2030 Including: 1) By Type: Automobile Dead Storage; Bulk Petroleum And Chemical Storage; Document Storage And Warehousing; Whiskey Warehousing; Other Specialized Warehousing And Storage Covering: Mitsubishi Logistics; Kuehne + Nagel International AG; Iron Mountain Inc; Kinder Morgan Inc; Apex Oil Company Inc
Specialized Warehousing And Storage Global Market Report 2021: COVID 19 Impact and Recovery to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
